Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SevenLac is an oral multi-strain probiotic dietary supplement marketed by Global Health Trax for digestive and intestinal health support. The product contains seven live bacterial ingredients \u2014 *Bacillus coagulans*, *Bacillus subtilis*, *Enterococcus faecalis*, *Lactobacillus acidophilus*, *Bifidobacterium longum*, *Lactobacillus rhamnosus*, and *Lactobacillus johnsonii* \u2014 and is sold as flavored powder packets. Its intended mechanism is microbiome modulation through replenishment of beneficial intestinal flora and support of gut bacterial balance rather than a single defined molecular target; it is marketed for symptoms such as bloating, gas, and irregular bowel movements, and also promoted for chronic conditions such as irritable bowel syndrome and allergies. SevenLac is a dietary supplement rather than an FDA-evaluated pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SevenLac.